| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |